New study tests sleep drug for night owls stuck on a late clock
NCT ID NCT06874855
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether the drug Lemborexant helps people with delayed sleep phase syndrome fall asleep faster at their desired bedtime. Fifteen adults will take either the drug or a placebo nightly for up to 2 years, tracking sleep with logs and a wrist monitor. The goal is to see if the drug can shift sleep timing and reduce daytime sleepiness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DELAYED SLEEP PHASE SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California San Francisco
RECRUITINGSan Francisco, California, 94107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.